TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06492122: Study With [225Ac]Ac-FL-020 in mCRPC Participants

Sponsor: Full-Life Technologies UK Limited · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 50 pts

Competing Trials Overlap

8 Active Trials

Excess Burn Exposure

$1,382,304

Rescue Site Savings

+$911,064

Unlock Full NCT06492122 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06492122 Rescue Dossier →